(E)-5-(hex-1-en-1-yl)-1,2,3-trimethoxybenzene

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (E)-5-(hex-1-en-1-yl)-1,2,3-trimethoxybenzene
• 英文别名: (E)-5-(hex-1-enyl)-1,2,3-trimethoxybenzene；5-[(E)-hex-1-enyl]-1,2,3-trimethoxybenzene
• 化学式: C₁₅H₂₂O₃
• 分子量: 250.338
• InChiKey: HRRPZBOJDJFQRK-CMDGGOBGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  18
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2,2-二甲基-2,6-二氢-吡喃并[3,2-c]喹啉-5-酮 、 (E)-5-(hex-1-en-1-yl)-1,2,3-trimethoxybenzene 以 neat (no solvent) 为溶剂， 反应 16.0h， 以14%的产率得到(1RS,2RS,2aRS,10aSR)-1-butyl,10,10-trimethyl-2-(3,4,5-trimethoxyphenyl)-1,2,2a,4,10,10a-hexahydro-3H-cyclobuta[4,5]pyrano[3,2-c]quinolin-3-one
  参考文献：
  名称：

  Euodenine A: A Small-Molecule Agonist of Human TLR4

  摘要：

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.

  DOI：

  10.1021/jm401321v
• 作为产物：
  描述：

  3,4,5-三甲氧基苯甲醛 在 silica gel 作用下， 以 1,4-二氧六环 、 乙醚 、 甲苯 为溶剂， 反应 16.0h， 生成 (E)-5-(hex-1-en-1-yl)-1,2,3-trimethoxybenzene
  参考文献：
  名称：

  Euodenine A: A Small-Molecule Agonist of Human TLR4

  摘要：

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.

  DOI：

  10.1021/jm401321v

文献信息

• One-step method for the synthesis of aryl olefins from aryl aldehydes and aliphatic aldehydes
  作者：Hanumant B. Borate、Supriya H. Gaikwad、Ananada S. Kudale、Subhash P. Chavan、Shrikant G. Pharande、Vitthal D. Wagh、Vikram S. Sawant

  DOI：10.1016/j.tetlet.2013.01.008

  日期：2013.3

  A conceptually new one-step reaction affording unexpected aryl olefinic product from aromatic aldehyde, aliphatic aldehyde and malononitrile in the presence of acetic acid-ammonium acetate under mild reaction conditions without using any metal catalyst is reported. This novel reaction was used to prepare a number of substituted aryl olefins including new molecules.

  据报道，在乙酸-乙酸铵存在下，在温和的反应条件下，无需使用任何金属催化剂，即可从芳香族醛，脂肪族醛和丙二腈得到意想不到的芳基烯烃产物，这是一种概念上新颖的一步反应。该新颖的反应用于制备包括新分子在内的许多取代的芳基烯烃。
• Synthesis, antiepileptic effects, and structure-activity relationships of α-asarone derivatives: In vitro and in vivo neuroprotective effect of selected derivatives
  作者：Jian Zhang、Keman Mu、Peng Yang、Xinqian Feng、Di Zhang、Xiangyu Fan、Qiantao Wang、Shengjun Mao

  DOI：10.1016/j.bioorg.2021.105179

  日期：2021.10

  moiety, the optimal activity was reached with either an allyl or a 1-butenyl group in conjugation with the benzene ring. The compounds 5 and 19 exerted better neuroprotective effects against epilepsy in vitro (cell) and in vivo (mouse) models. This study provides valuable data for further exploration and application of these compounds as potential anti-seizure medicines.

  在本研究中，我们使用 PTZ 诱导的癫痫模型比较了 α-细辛脑衍生物的抗癫痫作用，以探索其结构-活性关系。我们的研究表明，苯环 3,4,5-位上的供电子甲氧基可增加抗癫痫效力，但其他基团放置在不同位置会降低活性。此外，在烯丙基部分中，烯丙基或1-丁烯基与苯环共轭时可达到最佳活性。化合物5和19对体外（细胞）和体内（小鼠）模型的癫痫表现出更好的神经保护作用。该研究为进一步探索和应用这些化合物作为潜在的抗癫痫药物提供了有价值的数据。
• [EN] SINGLE-STEP PROCESS FOR THE PREPARATION OF ARYL OLEFINS<br/>[FR] PROCÉDÉ EN UNE ÉTAPE POUR LA PRÉPARATION D'ARYLOLÉFINES
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2014073003A1

  公开（公告）日：2014-05-15

  The present invention relates to the single-step process for the synthesis of aryl olefin compounds of Formula (1) by reacting aryl aldehydes with alkyl aldehydes in presence of malononitrile and acid or base or salt, optionally in presence of solvent.

  本发明涉及一种一步法合成芳基烯烃化合物的过程，该过程通过在存在丙二腈和酸或碱或盐的条件下，使芳基醛与烷基醛反应，可选地在溶剂的存在下进行。
• <i>Trans</i> Stereoselectivity in the Reaction of Cyclic Phosphonium Salts with Aromatic Aldehydes
  作者：Nicholas J. Lawrence、Hayrettin Beynek

  DOI：10.1055/s-1998-1702

  日期：1998.5

  The Wittig olefination of substituted aromatic aldehydes with ylides from phosphorinanium salts [RCH2P(Ph)(CH2)5]+Br- in which the phosphorus atom is incorporated into a six-membered ring, is E-selective.

  在磷鎓盐[RCH2P(Ph)(CH2)5]+Br-中，磷原子被纳入一个六元环内，以此类雌鎓与取代芳香醛进行Wittig烯化反应时，选择性地生成E型烯烃。
• Euodenine A: A Small-Molecule Agonist of Human TLR4
  作者：Juliette E. Neve、Hasanthi P. Wijesekera、Sandra Duffy、Ian D. Jenkins、Justin A. Ripper、Simon J. Teague、Marc Campitelli、Agatha Garavelas、George Nikolakopoulos、Phuc V. Le、Priscila de A. Leone、Ngoc B. Pham、Philip Shelton、Neil Fraser、Anthony R. Carroll、Vicky M. Avery、Christopher McCrae、Nicola Williams、Ronald J. Quinn

  DOI：10.1021/jm401321v

  日期：2014.2.27

  A small-molecule natural product, euodenine A (1), was identified as an agonist of the human TLR4 receptor. Euodenine A was isolated from the leaves of Euodia asteridula (Rutaceae) found in Papua New Guinea and has an unusual U-shaped structure. It was synthesized along with a series of analogues that exhibit potent and selective agonism of the TLR4 receptor. SAR development around the cyclobutane ring resulted in a 10-fold increase in potency. The natural product demonstrated an extracellular site of action, which requires the extracellular domain of TLR4 to stimulate a NF-kappa B reporter response. 1 is a human-selective agonist that is CD14-independent, and it requires both TLR4 and MD-2 for full efficacy. Testing for immunomodulation in PBMC cells shows the induction of the cytokines IL-8, IL-10, TNF-alpha, and IL-12p40 as well as suppression of IL-5 from activated PBMCs, indicating that compounds like 1 could modulate the Th2 immune response without causing lung damage.